After a site visit to NUH in April, the HTA found the Nottingham Health Science Biobank to fully satisfy their rigorous criteria for approval.
The HTA found the Designated Individual and the Licence Holder to be suitable in accordance with … Continue reading
by Balwir Matharoo-Ball
The Nottingham Health Science Biobank (NHSB) and related bioinformatics strategy as a platform for excellence in translational and clinical research is led by Dr Brian Thomson Director of Department of Research and Innovation (R&I) and the NHSB. This … Continue reading
The Nottingham Research Biobank has now received Ethical Approval. This is the first formal step in our co-ordinated biobanking and patient informatics strategy. The Ethics approval itself has a number of unique features, and is by far the most comprehensive … Continue reading
During 2012/13 NUH delivered significant improvements in research initiation and delivery. Performance against NIHR contract benchmarks for research initiation and delivery improved by 36% yoy
All NHS organisations are required to publish information on clinical trials regarding the 70 day benchmark of recruiting the first patient within 70 days of a valid submission and recruiting to time and target for commercial clinical trials.
How well we … Continue reading
The East Midlands Academic Health Science Network and Medilink are hosting an event entitled ‘IGNITING INNOVATION’ EXPERIMENTAL MEDICINE – WORKING TOGETHER on Monday 4 March 2013 at BioCity, Nottingham.
During 2011/12 NUH maintained excellence in research in a changing and challenging environment. Key achievements during this period include 8,874 patients recruited in 293 NIHR adopted studies, 1644 patients recruited to 157 commercial studies, 14 new NIHR research grants awarded, £8.7M external funding attracted by three BRUs, More than 4,000 biosamples and £420K of external funding for the Nottingham Health Science Biobank. Continue reading
Nottingham University Hospitals ‐ Delivering exceptional service for external clinical evaluations
The external evaluation of any diagnostic kit is the cornerstone for the commercial release of any product in the medical industry. R&D activities are focused on achieving product design requirements, … Continue reading
Dr Brian Thomson
Director of Nottingham Health Science Biobank and Director of R&I
Email: email@example.com | Tel: 0115 823 1832
Prof. Ian Ellis
Co-Director of Nottingham Health Science Biobank
Email: firstname.lastname@example.org | Tel: 0115 969 1169 ext. 56875
Dr Balwir Matharoo-Ball
Operations Manager for Translational Research … Continue reading
This year’s annual report provides a summary of research activity at NUH during 2010/11, and describes progress against the NUH R&D Strategy. During this period NUH increased recruitment to NIHR portfolio clinical trials by 46%, ranking amongst the top six NHS Trusts in the country and increased research income from the NIHR and NIHR partners by 50%. Continue reading